Collegium Pharmaceutical, Inc.
NASDAQ:COLL
34.71 (USD) • At close November 7, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Activities: | |||||||||||
| Net Income
| 48.155 | -25.002 | 71.517 | 26.752 | -22.722 | -39.128 | -74.865 | -94.176 | -27.255 | -17.917 | -16.197 |
| Depreciation & Amortization
| 149.256 | 138.939 | 68.917 | 61.55 | 15.483 | 110.908 | 0.594 | 0.655 | 0.171 | 0.187 | 0.169 |
| Deferred Income Tax
| -2.153 | -8.391 | -78.042 | 0 | 0 | 0 | 1.845 | 0 | 0 | 0 | 0.079 |
| Stock Based Compensation
| 27.136 | 22.874 | 24.255 | 21.91 | 16.528 | 13.778 | 7.945 | 5.787 | 2.209 | 0.022 | 0.062 |
| Change In Working Capital
| 21.731 | -12.713 | 13.486 | -25.299 | 18.181 | 64.551 | -2.503 | 12.715 | 3.336 | -0.219 | -0.634 |
| Accounts Receivables
| 3.594 | -21.78 | -22.524 | -10.367 | 4.993 | -68.231 | -7.84 | -2.129 | 0 | 0 | 0 |
| Inventory
| 14.169 | 48.274 | -2.296 | -8.27 | -1.826 | 0.219 | -0.497 | -1.316 | 0 | 0 | 0 |
| Accounts Payables
| 5.061 | -0.707 | -5.827 | 3.769 | -5.903 | 6.465 | -3.422 | 5.569 | 1.298 | 0.99 | -0.822 |
| Other Working Capital
| -1.093 | -38.5 | 44.133 | -10.431 | 20.917 | 126.098 | 9.256 | 10.591 | 2.038 | -1.209 | 0.188 |
| Other Non Cash Items
| 30.624 | 8.523 | 3.424 | 9.029 | 0.313 | 19.281 | -0.034 | -0.034 | -0.028 | -0.02 | -0.009 |
| Operating Cash Flow
| 274.749 | 124.23 | 103.557 | 93.942 | 27.783 | 169.39 | -67.018 | -75.053 | -21.567 | -17.947 | -16.53 |
| Investing Activities: | |||||||||||
| Investments In Property Plant And Equipment
| -0.461 | -1.622 | -1.944 | -373.772 | -6.438 | -24.354 | -0.99 | -2.977 | -0.362 | -0.008 | -0.206 |
| Acquisitions Net
| 0 | -572.069 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Purchases Of Investments
| -92.351 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Sales Maturities Of Investments
| 22 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Investing Activites
| -70.351 | 0 | 0 | -368.226 | 0 | -18.877 | 0 | -2.5 | 0 | 0 | 0 |
| Investing Cash Flow
| -70.812 | -573.691 | -1.944 | -373.772 | -6.438 | -24.354 | -0.99 | -2.977 | -0.362 | -0.008 | -0.206 |
| Financing Activities: | |||||||||||
| Debt Repayment
| -59.638 | -75 | -50 | -289.323 | 0 | -10.021 | -2.667 | -2.667 | -1.345 | -0.09 | -0.105 |
| Common Stock Issued
| 9.101 | 11.811 | 12.707 | 7.335 | 2.863 | -0.03 | 34.338 | 138.225 | 117.353 | 0 | 0 |
| Common Stock Repurchased
| -83.361 | -14.063 | -52.01 | -2.255 | -0.822 | -0.03 | 1.141 | 0 | 0 | 0 | 0 |
| Dividends Paid
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | -24.572 | -24.572 | 0 | 0 |
| Other Financing Activities
| 2.821 | 513.975 | 12.707 | -0.594 | 2.863 | -117.137 | 1.404 | 138.225 | 117.337 | 12.128 | 12.456 |
| Financing Cash Flow
| -140.178 | 436.723 | -89.303 | 286.474 | 2.041 | -117.197 | 33.48 | 135.558 | 115.992 | 12.038 | 12.351 |
| Other Information: | |||||||||||
| Effect Of Forex Changes On Cash
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net Change In Cash
| 63.759 | -12.738 | 12.31 | 6.644 | 23.386 | 27.839 | -34.528 | 57.528 | 94.063 | -5.917 | -4.385 |
| Cash At End Of Period
| 239.994 | 176.235 | 188.973 | 176.663 | 170.019 | 146.633 | 118.697 | 153.225 | 95.697 | 1.634 | 7.551 |